コンビネーション医薬品（DDS）の世界市場

Report Highlights

The global market for drug-device combinations is expected to grow from $129.4 billion in 2024 and is projected to reach $199.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 9.1% during the forecast period of 2024 to 2029.

コンビネーション医薬品（DDS）の世界市場は、2024 年の 1,294 億ドルから成長し、2024 年から 2029 年の予測期間中の年間平均成長率 (CAGR) 9.1% で、2029 年末までに 1,998 億ドルに達すると予測されています。

Report Ovewview

Summary:

The global market for drug-device combination products was valued at $119.4 billion in 2023. The market is expected to grow at a compound annual growth rate (CAGR) of 9.1%, reaching about $199.8 billion by the end of 2029. Growth of the global market is attributed to factors such as the wide range of potential applications of drug-device combinations, the increasing number of diseases and the recent approvals of novel drug-device combination products.

The primary driver fueling the expansion of the global market for drug-device combination products is the rising prevalence of chronic diseases. The rise in chronic conditions has led to a surge in demand for diagnostic services, early detection technologies and preventive healthcare solutions. According to America’s Health Rankings 2023 Annual Report, by 2022, over 29 million U.S. adults reported having three or more chronic conditions. Similarly, the World Health Organization (WHO) states that chronic diseases account for 71% of global deaths annually. The prevalence of diabetes rises with age, with 29.2% of individuals aged 65 years or older affected. According to the IDF Diabetes Atlas 10th Edition  2021, the estimated number of people aged 20 to 79 with diabetes has shown a significant increase: 151  million in 2000, 366 million in 2011, 536.6 million in 2021, and projected 642.8 million by 2030 and  783.7 million by 2045. These conditions, such as diabetes, cardiovascular diseases and respiratory disorders, demand continuous and precise management, which combination products effectively provide. For instance, insulin pumps for diabetes and drug-eluting stents for cardiovascular issues offer targeted and controlled drug delivery, enhancing treatment efficacy and patient compliance.

Additionally, products like inhalers and pre-filled syringes simplify administration, making it easier for patients to adhere to their regimens. Technological advancements and regulatory support also facilitate the development and adoption of innovative drug-device combinations, driving market growth.

The market has been segmented based on product type, application and geography. Based on product type, the market in this report is segmented into drug-device combination products such as drug-eluting stents (DES), antimicrobial catheters, photodynamic therapy, autoinjectors, transdermal patches, metered dose inhalers and others), device/biologic drug-device combination products (microneedles, prefilled syringe (PFS), nasal inhalers, nanotechnology generated, implants and others), drug/biologic drug-device combination products (monoclonal antibodies, antibody-drug conjugates (ADC), wound care and others) and drug, device and biologic. Based on application, the drug-device combination product market is segmented by treatment of the following diseases: oncology, cardiovascular diseases, metabolic disorders, respiratory diseases orthopedic diseases and others.

Report Scope:

The global market for drug-device combination is a rapidly expanding healthcare industry segment, encompassing products that integrate pharmaceutical drugs with medical devices to enhance treatment efficacy and patient convenience. The current report provides a comprehensive introduction and delves into the market for drug-device combinations. It examines market trends of these products, utilizing data from 2021, estimates for 2024 and projections of compound annual growth rates spanning 2024 through 2029 (forecast period) and regional markets of the drug-device combination product market. This report highlights drug-device combinations’ current and future market potential and a detailed competitive environment analysis. It covers the regulatory scenario, drivers, restraints, challenges, opportunities, emerging technologies and sustainability in drug-device combinations. The report also covers market projections for 2029 and the market share for key market players. The report informs all market players, potential entrants, government agencies and other interested parties. It covers geographic regions in detail, so companies interested in expanding their geographic reach will also find this study helpful.

Report Includes:

– 40 data tables and 43 additional tables
– Overview of the global markets for drug-device combination (DDC) products and biological devices
– Analyses of global market trends, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
– Estimate of the current market size and revenue prospects of the global market, along with a market share analysis by product type, application (disease area), and region
– Facts and figures pertaining to the market dynamics, current and emerging technologies, regulations, prospects, product recalls, pipeline products, and the expected impact of macroeconomic factors
– Review of the industry supply chain, using the Porter’s Five Forces model, to analyze the micro- and macro environmental factors prevailing in the marketplace
– Overview of ESG developments and sustainability trends in the industry, with a focus on consumer attitudes, companies’ ESG score rankings and their ESG practices
– An analysis of the industry structure, including companies’ market shares, alliances, M&A activity and venture funding outlook
– Profiles of the leading market players, including Medtronic, Boston Scientific Corp., Stryker, Abbott, and BD

Table of Contents

Table of Contents

Chapter 1 Executive Summary

Market Outlook

Scope of Report

Market Summary

Chapter 2 Market Overview

Market Insights

Regulatory Landscape

Patent Review

Product Recalls

Product Pipeline

Chapter 3 Market Dynamics

Market Dynamics Snapshot

Drivers

Wide Range of Potential Applications of Combinations Products

Growing Prevalence of Chronic Diseases

Empowering Patients: Integrating Homecare Trends with Drug Delivery Advancements

Restraints

Device Reliability and Robustness

Human Factors Testing

Drug and Device Integration

Accommodating Different Volumes

Challenges

Biological Safety Challenges in Drug-Device Combinations

Regulatory Challenges

Opportunities

Technology advancements and Innovative Product Launches

Continuous Growth

Key Players Focusing on Inorganic Strategies in the Drug-Device Combination Products Market

Chapter 4 Market Segmentation Analysis

Segmentation Breakdown

Drug-Device Combinations Market by Product Type

Drug/Biologic-Device Combination Products

Drug-Biologic Drug-Device Combination Products

Drug, Device and Biologic Combination Products

Drug-Device Combinations Market by Application

Cardiovascular Diseases

Metabolic Disorders

Respiratory Diseases

Wound Care

Oncology

Orthopedic Conditions

Others

Geographic Breakdown

Drug-Device Combinations Market, by Region

North America

Europe

Asia-Pacific

Rest of the World

Chapter 5 Emerging Trends and Technologies

Overview

AI in Drug-Device Combination

Nanotechnology

Computational Models and Simulation

Human Organs-on-Chips: Revolutionizing Medical Research

Implantable Drug Delivery Systems

Wireless Implants

Smart Drug Delivery Devices for 3D Printing

Recent Approvals and Launch of Novel Drug-device Combination Products

Chapter 6 ESG Development

Introduction

ESG Sustainability in Drug-Device Combinations Market

ESG Risk Ratings

WHO Guidelines and Global Initiatives

BCC Research Viewpoint

Chapter 7 Competitive Landscape

Company Share Analysis

Mergers, Acquisitions and Collaborations

Strategic Alliances

Chapter 8 Appendix

Methodology

Sources

Abbreviations

Company Profiles

3M

ABBOTT

1. BRAUN SE

BD

BOSTON SCIENTIFIC CORP.

JOHNSON & JOHNSON SERVICES INC.

MEDTRONIC

SMITH+NEPHEW

STRYKER

TERUMO CORP.

List Of Tables

List of Tables

Summary Table : Global Market for Drug-Device Combinations, by Product Type, Through 2029

Table 1 : EU Combination Product Regulation

Table 2 : Granted Patents on Drug-Device Combination Products in 2024, U.S.

Table 3 : Recalled Drug-Device Combination Products, 2021–2024

Table 4 : Drug-Device Combination Product Pipeline

Table 5 : Projected Number of Adults 50 Years and Older With ≥1 Chronic Condition in the United States, 2020–2050

Table 6 : Global Market for Drug-Device Combination Products, by Product Type, Through 2029

Table 7 : Global Market for Drug/Biologic-Device Combination Products, by Product Type, Through 2029

Table 8 : Global Market for Drug Eluting Stents (DES), by Region, Through 2029

Table 9 : Marketed or Late-stage Development Products in DCDs

Table 10 : Global Market for Prefilled Syringe (PFS), by Region, Through 2029

Table 11 : Global Market for Inhalers, by Region, Through 2029

Table 12 : Global Market for Nebulizers, by Region, Through 2029

Table 13 : Global Market for Wound Care Products, by Region, Through 2029

Table 14 : Global Market for Implants, by Region, Through 2029

Table 15 : Available Catheter Types in Clinical Use, 2022

Table 16 : Global Market for Antimicrobial Catheters, by Region, Through 2029

Table 17 : Global Market for Transdermal Patches, by Region, Through 2029

Table 18 : Global Market for Photodynamic Therapy (PDT), by Region, Through 2029

Table 19 : Global Market for Other Types of Drug-Device Combination Products, by Region, Through 2029

Table 20 : Global Market for Drug-Biologic Combination Products, by Product Type, Through 2029

Table 21 : FDA Approved ADCs

Table 22 : Global Market for Antibody Drug Conjugates (ADC), by Region, Through 2029

Table 23 : Global Market for Monoclonal Antibodies (mAbs), by Region, Through 2029

Table 24 : Global Market for Other Types of Drug-Biologic Combination Products, by Region, Through 2029

Table 25 : Global Market for Drug-Device Combination Products, by Application, Through 2029

Table 26 : Global Market for Drug-Device Combination Products for Cardiovascular Diseases, by Region, Through 2029

Table 27 : Global Market for Drug-Device Combination Products for Metabolic Disorders, by Region, Through 2029

Table 28 : Global Market for Drug-Device Combination Products for Respiratory Diseases, by Region, Through 2029

Table 29 : Global Market for Drug-Device Combination Products for Wound Care, by Region, Through 2029

Table 30 : Global Market for Drug-Device Combination Products in Oncology, by Region, Through 2029

Table 31 : Global Market for Drug-Device Combination Products for Orthopedic Conditions, by Region, Through 2029

Table 32 : Global Market for Drug-Device Combination Products for Other Chronic Diseases, by Region, Through 2029

Table 33 : Global Market for Drug-Device Combination Products, by Region, Through 2029

Table 34 : North American Market for Drug-Device Combination Products, by Country, Through 2029

Table 35 : European Market for Drug-Device Combination Products, by Country, Through 2029

Table 36 : Asia-Pacific Market for Drug-Device Combination Products, by Country, Through 2029

Table 37 : ESG Highlights, by Major Players, 2023

Table 38 : ESG Rankings for Major Drug-Device Combinations Manufacturing Companies, 2023

Table 39 : Market Players and the Products They Offer for Various Applications

Table 40 : Mergers and Acquisitions: Drug-Device Combination Products Manufacturers, 2021–2024

Table 41 : Major Strategic Alliances in the Drug-Device Combination Industry, 2021–2024

Table 42 : Information Sources in this Report

Table 43 : Major Abbreviations Used in This Report

Table 44 : 3M: Company Snapshot

Table 45 : 3M: Financial Performance, FY 2022 and 2023

Table 46 : 3M: Products Portfolio

Table 47 : 3M: News/Key Developments, 2023

Table 48 : Abbott: Company Snapshot

Table 49 : Abbott: Financial Performance, FY 2022 and 2023

Table 50 : Abbott: Products Portfolio

Table 51 : Abbott: News/Key Developments, 2024

Table 52 : B Braun SE: Company Snapshot

Table 53 : B Braun SE: Financial Performance, FY 2022 and 2023

Table 54 : B. Braun SE: Products Portfolio

Table 55 : B. Braun SE: News/Key Developments, 2022

Table 56 : BD: Company Snapshot

Table 57 : BD: Financial Performance, FY 2022 and 2023

Table 58 : BD: Product Portfolio

Table 59 : BD: News/Key Developments, 2023

Table 60 : Boston Scientific Corp.: Company Snapshot

Table 61 : Boston Scientific Corp.: Financial Performance, FY 2022 and 2023

Table 62 : Boston Scientific Corp.: Products Portfolio

Table 63 : Boston Scientific Corp.: News/Key Developments, 2024

Table 64 : Johnson & Johnson Services Inc.: Company Snapshot

Table 65 : Johnson & Johnson Services Inc.: Financial Performance, FY 2022 and 2023

Table 66 : Johnson & Johnson Services Inc.: Product Portfolio

Table 67 : Johnson & Johnson Services Inc.: News/Key Developments, 2022

Table 68 : Medtronic: Company Snapshot

Table 69 : Medtronic: Financial Performance, FY 2022 and 2023

Table 70 : Medtronic: Products Portfolio

Table 71 : Medtronic: News/Key Developments, 2024

Table 72 : Smith+Nephew: Company Snapshot

Table 73 : Smith+Nephew: Financial Performance, FY 2022 and 2023

Table 74 : Smith+Nephew: Products Portfolio

Table 75 : Smith+Nephew: News/Key Developments, 2024

Table 76 : Stryker: Company Snapshot

Table 77 : Stryker: Financial Performance, FY 2022 and 2023

Table 78 : Stryker: Products Portfolio

Table 79 : Terumo Corp.: Company Snapshot

Table 80 : Terumo Corp.: Financial Performance, FY 2022 and 2023

Table 81 : Terumo Corp.: Product Portfolio

Table 82 : Terumo Corp.: News/Key Developments, 2023

List Of Figures

List of Figures

Summary Figure : Global Market for Drug-Device Combinations, by Product Type, 2021–2029

Figure 1 : U.S. FDA Combination Product Approval Pathway

Figure 2 : Snapshot of the Global Markets for Drug-Device Combinations

Figure 3 : Share of New Cancer Cases (Incidence) Globally, by Region, 2022

Figure 4 : Share of Cancer Mortality Cases Globally, by Region, 2022

Figure 5 : Global Market Shares of Drug-Device Combination Products, by Product Type, 2023

Figure 6 : Global Market for Drug-Device Combination Products, by Region, 2021–2029

Figure 7 : Global Market Shares of Drug-Device Combination Products, by Region, 2023

Figure 8 : Traditional and New Generation Drug-Device Combination

Figure 9 : Global Market Shares of Drug-Device Combination Products, by Company, 2023

Figure 10 : 3M: Revenue Share, by Country/Region, FY 2023

Figure 11 : 3M: Revenue Share, by Business Unit, FY 2023

Figure 12 : Abbott: Revenue Share, by Country/Region, FY 2023

Figure 13 : Abbott: Revenue Share, by Business Unit, FY 2023

Figure 14 : B Braun SE: Revenue Share, by Country/Region, FY 2023

Figure 15 : B Braun SE: Revenue Share, by Business Unit, FY 2023

Figure 16 : BD: Revenue Share, by Country/Region, FY 2023

Figure 17 : BD: Revenue Share, by Business Unit, FY 2023

Figure 18 : Boston Scientific Corp.: Revenue Share, by Country/Region, FY 2023

Figure 19 : Boston Scientific Corp.: Revenue Share, by Business Unit, FY 2023

Figure 20 : Johnson & Johnson Services Inc.: Revenue Share, by Country/Region, FY 2023

Figure 21 : Johnson & Johnson Services Inc.: Revenue Share, by Business Unit, FY 2023

Figure 22 : Medtronic: Revenue Share, by Country/Region, FY 2023

Figure 23 : Medtronic: Revenue Share, by Business Unit, FY 2023

Figure 24 : Smith+Nephew: Revenue Share, by Country/Region, FY 2023

Figure 25 : Smith+Nephew: Revenue Share, by Business Unit, FY 2023

Figure 26 : Stryker: Revenue Share, by Country/Region, FY 2023

Figure 27 : Stryker: Revenue Share, by Business Unit, FY 2023

Figure 28 : Terumo Corp.: Revenue Share, by Country/Region, FY 2023

Figure 29 : Terumo Corp.: Revenue Share, by Business Unit, FY 2023

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 食品小売業およびEコマースにおけるAIの世界市場 2025-11-14
• 免疫療法薬の世界市場 2025-11-12
• 農業におけるAIの世界市場 2025-11-10
• 固体酸化物形燃料電池の技術と世界市場 2025-11-07
• 世界の電気アーク炉市場 2025-11-07

BCC Research  出版レポート一覧